Singapore markets close in 7 hours 1 minute

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
57.60-0.64 (-1.10%)
At close: 04:00PM EDT
57.60 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate-1.31-1.34-5.16-5.41
Low estimate-1.7-1.79-6.3-6.98
High estimate-1.1-1.1-4.41-3.72
Year ago EPS-1.27-1.33-5.2-5.16
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8899
Avg. EstimateN/AN/A6.33M20k
Low estimateN/AN/AN/AN/A
High estimateN/AN/A30M200k
Year ago salesN/AN/A151k6.33M
Sales growth (year/est)N/AN/A4,092.10%-99.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.34-1.35-1.37-1.35
Actual EPS-1.27-1.33-1.34-1.21
Difference0.070.020.030.14
Surprise %5.20%1.50%2.20%10.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.31-1.34-5.16-5.41
7 days ago-1.34-1.37-5.27-5.47
30 days ago-1.34-1.37-5.27-5.47
60 days ago-1.33-1.36-5.15-5.6
90 days ago-1.36-1.4-5.24-5.59
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2333
Up last 30 days2333
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKROSIndustrySector(s)S&P 500
Current qtr.-3.10%N/AN/AN/A
Next qtr.-0.80%N/AN/AN/A
Current year0.80%N/AN/AN/A
Next year-4.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A